title: Natural killer cells act as rheostats modulating antiviral T cells.
abstract: Antiviral T cells are thought to regulate whether hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections result in viral control, asymptomatic persistence or severe disease, although the reasons for these different outcomes remain unclear. Recent genetic evidence, however, has indicated a correlation between certain natural killer (NK)-cell receptors and progression of both HIV and HCV infection, implying that NK cells have a role in these T-cell-associated diseases. Although direct NK-cell-mediated lysis of virus-infected cells may contribute to antiviral defence during some virus infections--especially murine cytomegalovirus (MCMV) infections in mice and perhaps HIV in humans--NK cells have also been suspected of having immunoregulatory functions. For instance, NK cells may indirectly regulate T-cell responses by lysing MCMV-infected antigen-presenting cells. In contrast to MCMV, lymphocytic choriomeningitis virus (LCMV) infection in mice seems to be resistant to any direct antiviral effects of NK cells. Here we examine the roles of NK cells in regulating T-cell-dependent viral persistence and immunopathology in mice infected with LCMV, an established model for HIV and HCV infections in humans. We describe a three-way interaction, whereby activated NK cells cytolytically eliminate activated CD4 T cells that affect CD8 T-cell function and exhaustion. At high virus doses, NK cells prevented fatal pathology while enabling T-cell exhaustion and viral persistence, but at medium doses NK cells paradoxically facilitated lethal T-cell-mediated pathology. Thus, NK cells can act as rheostats, regulating CD4 T-cell-mediated support for the antiviral CD8 T cells that control viral pathogenesis and persistence.
authors.affiliation: Department of Pathology and Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
authors.forename: Stephen N
authors.initials: SN
authors.lastname: Waggoner
authors.forename: Markus
authors.initials: M
authors.lastname: Cornberg
authors.forename: Liisa K
authors.initials: LK
authors.lastname: Selin
authors.forename: Raymond M
authors.initials: RM
authors.lastname: Welsh
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D004195:Disease Models, Animal; D015658:HIV Infections / Q000276:immunology; D006526:Hepatitis C / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D007694:Killer Cells, Natural / Q000166:cytology / Q000276:immunology*; D018655:Lymphocyte Count; D008216:Lymphocytic Choriomeningitis / Q000276:immunology / Q000473:pathology / Q000821:virology; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology* / Q000472:pathogenicity; D051379:Mice; D008810:Mice, Inbred C57BL; D018448:Models, Immunological; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*
chemical_list: D007371:Interferon-gamma
references.citation: EMBO J. 1989 Mar;8(3):719-27
references.pmid: 2524380
references.citation: Nat Genet. 2002 Aug;31(4):429-34
references.pmid: 12134147
references.citation: Immunology. 2003 Dec;110(4):519-26
references.pmid: 14632651
references.citation: Curr Top Microbiol Immunol. 2002;263:83-117
references.pmid: 11987822
references.citation: Eur J Immunol. 1995 Dec;25(12):3402-11
references.pmid: 8566030
references.citation: Int J Cancer. 1991 Feb 20;47(4):527-32
references.pmid: 1671670
references.citation: J Virol. 1994 Jul;68(7):4700-4
references.pmid: 7911534
references.citation: J Exp Med. 1984 Aug 1;160(2):521-40
references.pmid: 6332167
references.citation: Virology. 1998 Jan 5;240(1):158-67
references.pmid: 9448700
references.citation: Science. 2004 Aug 6;305(5685):872-4
references.pmid: 15297676
references.citation: J Exp Med. 1978 Jul 1;148(1):163-81
references.pmid: 307587
references.citation: Eur J Immunol. 2001 Oct;31(10):3048-55
references.pmid: 11592081
references.citation: Immunity. 2009 Aug 21;31(2):270-82
references.pmid: 19631564
references.citation: J Virol. 1994 Dec;68(12):8056-63
references.pmid: 7966595
references.citation: Science. 2009 Jun 19;324(5934):1572-6
references.pmid: 19443735
references.citation: J Immunol. 2011 Mar 15;186(6):3304-8
references.pmid: 21307295
references.citation: J Clin Invest. 2010 Jun;120(6):1925-38
references.pmid: 20440077
references.citation: PLoS Pathog. 2007 Aug 24;3(8):e123
references.pmid: 17722980
references.citation: Science. 2009 Jun 19;324(5934):1569-72
references.pmid: 19423777
references.citation: J Exp Med. 1998 Dec 21;188(12):2205-13
references.pmid: 9858507
references.citation: Science. 2009 Jun 19;324(5934):1576-80
references.pmid: 19478140
references.citation: Nat Immun Cell Growth Regul. 1985;4(1):21-39
references.pmid: 3875791
references.citation: J Virol. 2000 Aug;74(15):6922-34
references.pmid: 10888631
references.citation: Immunity. 2004 Jun;20(6):757-67
references.pmid: 15189740
references.citation: J Exp Med. 1991 May 1;173(5):1053-63
references.pmid: 1850779
references.citation: J Immunol. 2006 Nov 15;177(10):6588-92
references.pmid: 17082569
references.citation: J Immunol. 2010 Jun 15;184(12):6790-8
references.pmid: 20488796
references.citation: J Immunol. 1983 Sep;131(3):1531-8
references.pmid: 6309965
references.citation: J Exp Med. 2010 Jun 7;207(6):1333-43
references.pmid: 20513749
references.citation: J Immunol. 2004 Sep 15;173(6):3653-9
references.pmid: 15356110
references.citation: Nature. 2011 Aug 03;476(7358):96-100
references.pmid: 21814282
references.citation: J Immunol. 2003 Apr 1;170(7):3572-6
references.pmid: 12646619
references.citation: J Immunol. 2004 Apr 1;172(7):4204-14
references.pmid: 15034033
references.citation: Nat Immun Cell Growth Regul. 1986;5(4):169-99
references.pmid: 2430177
references.citation: Virology. 1990 Oct;178(2):393-400
references.pmid: 1699348
references.citation: J Virol. 1984 Oct;52(1):119-28
references.pmid: 6207307